Morgan Stanley analyst Devin McDermott downgrades Devon Energy (NYSE:DVN) from Overweight to Equal-Weight and raises the price target from $28 to $32.
HC Wainwright & Co. Maintains Buy on Foghorn Therapeutics, Lowers Price Target to $18
HC Wainwright & Co. analyst Andrew Fein maintains Foghorn Therapeutics (NASDAQ:FHTX) with a Buy and lowers the price target from $25 to $18.